The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Reine Allan since 2017.
This trader's CIK number is 1714023.
At the time of last reporting, Reine Allan was the Chief Executive Officer of Prime Medicine, Inc.. (stock ticker symbol PRME).
Also see all insider trading activities at Prime Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PRME | 125,000 | $147,125 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | FHTX | 0 | $0 | 0 | $0 | 26,892 | $100,038 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | PIRS | 65,000 | $313,350 | 0 | $0 | 0 | $0 |
1. Prime Medicine, Inc. (PRME)
2. Foghorn Therapeutics Inc. (FHTX)
3. Palvella Therapeutics, Inc. (PIRS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-21 | PRME | Buy | 125,000 | 1.18 | 147,125 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-09 | FHTX | Option Ex | 26,892 | 3.72 | 100,038 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-17 | PIRS | Buy | 20,000 | 4.89 | 97,800 |
| 2017-08-16 | PIRS | Buy | 45,000 | 4.79 | 215,550 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reine Allan (Chief Executive Officer of Prime Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.